Representatives of NJOY released a statement Wednesday night defending the company's product.
"NJOY's products have been on the market since at least April 2007 with no reports of adverse health consequences," company CEO Jack Leadbeater said in a statement. "We do not market our products to children, and indeed take affirmative steps to ensure that our products are not sold to minors by requiring retailers to agree to where the product is placed and request verification of appropriate age as it pertains to each state law."
"NJOY has been tested by an independent third-party laboratory. This testing, as well as our consultation with medical experts, gives us confidence that our products are appropriate alternatives for traditional cigarettes for the committed smoker," Leadbeater continued. "We are therefore surprised the FDA's testing has resulted in the agency suggesting that our products represent a health risk on par with conventional cigarettes. We will provide more information on NJOY's testing and the results in the very near future."
Smoking Everywhere did not return phone calls seeking comment.
The U.S. Food and Drug Administration has more on e-cigarettes.
Copyright © 2011 HealthDay. All rights reserved.